Lambert, Judith
Leutenegger, Anne-Louise
Baudot, Anaïs
Jannot, Anne-Sophie
Funding for this research was provided by:
Inserm cross-cutting program Genomic variability 2018 GOLD
Article History
Received: 16 June 2023
Accepted: 3 January 2025
First Online: 15 March 2025
Declarations
:
: All methods were carried out in accordance with the RECORD (REporting of studies Conducted using Observational Routinely-collected Data) statement. This study has been declared to INSERM (Institut National de la Santé et de la Recherche Médicale, ). The data from this study are extracted from the EGB (Échantillon Généraliste des Bénéficiaires), a permanent 1/97 representative sample of the National Health Data System (Système National de Données de Santé, SNDS). The information provided to individuals in EGB on the possible re-use of their data and the procedures for exercising their rights comply with the legislative and regulatory provisions applicable to the processing of personal data in the SNDS. According to French regulations, informed consent is not required for secondary data reuse, but patient information is mandatory. Therefore, individuals in SNDS database are informed of the reuse of their data for research and can opposed to this reuse as defined by Articles 92 to 95 of Decree No. 2005 − 1309 of 20 October 2005 (). EGB data, which is part of the SNDS, can be reused for research projects from authorized persons once the research project is declared to their institution (INSERM). Institutional review board approval was not required for this study because the research was based on the secondary use of the EGB (Échantillon Généraliste des Bénéficiaires) medico-administrative database, which is a random sample of 1/97 of the French National medico-administrative database.
: Not applicable.
: The authors declare no competing interests.